Cryoport (NASDAQ: CYRX) CEO granted 492,901 options, sells 7,918 shares for taxes

Rhea-AI Filing Summary

Cryoport, Inc. President and CEO Jerrell Shelton reported two transactions. He sold 7,918 shares of Common Stock at $8.00 per share on March 16, 2026, with a footnote stating the shares were required to be sold to pay taxes due on vesting of restricted stock rights. After this tax-related sale, he directly owned 1,054,501 Common shares. On March 14, 2026, he also received a grant of 492,901 stock options with an exercise price of $8.60 per share, expiring on March 14, 2033; 1/48 of these options vest on the 14th of each month over 48 months beginning April 14, 2026.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

SHELTON JERRELL

(Last) (First) (Middle)

C/O CRYOPORT INC.

112 WESTWOOD PLACE, SUITE 350

(Street)

BRENTWOOD TN 37027

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Cryoport, Inc. [ CYRX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President, CEO

3. Date of Earliest Transaction (Month/Day/Year)
03/14/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/16/2026		S(1)		7,918	D	$8	1,054,501	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	$8.6	03/14/2026		A		492,901		(2)	03/14/2033	Common Stock	492,901	$0	492,901	D

Explanation of Responses:

1. Shares required to be sold in accordance with the Issuer's policies, in payment of taxes due upon the vesting of restricted stock rights.

2. 1/48 of options vest on the 14th of each month for forty-eight months beginning April 14, 2026.

	/s/ Jerrell Shelton	03/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did Cryoport (CYRX) CEO Jerrell Shelton report?

Jerrell Shelton reported a tax-related sale of 7,918 Cryoport Common shares and a large stock option grant. The sale occurred at $8.00 per share, while the new award covers 492,901 options at an exercise price of $8.60 per share.

How many Cryoport (CYRX) shares did the CEO sell and for what purpose?

He sold 7,918 Common shares at $8.00 per share. A footnote explains the shares were required to be sold under company policies to pay taxes due upon vesting of restricted stock rights, indicating this was a tax-related, non-discretionary disposition.

What stock options were granted to the Cryoport (CYRX) CEO in this Form 4?

He received 492,901 stock options with an exercise price of $8.60 per share. These options relate to Cryoport Common Stock and expire on March 14, 2033, representing a significant long-term equity incentive tied to future share price performance.

How do the new Cryoport (CYRX) CEO options vest over time?

The grant vests gradually, with 1/48 of the options vesting on the 14th of each month for 48 months. Vesting begins on April 14, 2026, creating a four-year monthly vesting schedule that encourages long-term retention and performance alignment.

How many Cryoport (CYRX) shares does the CEO hold after these transactions?

After the reported sale, Jerrell Shelton directly holds 1,054,501 shares of Cryoport Common Stock. In addition, he holds a newly granted option covering 492,901 shares, which becomes exercisable over time according to the disclosed four-year monthly vesting schedule.

Are the Cryoport (CYRX) CEO’s reported share sales discretionary?

The filing states the 7,918 shares sold were required under company policies to pay taxes due on restricted stock vesting. This language indicates a tax-withholding related sale rather than a discretionary open-market reduction in the CEO’s economic exposure to Cryoport shares.